Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Psychopharmacology

• Publication date

  2018-02-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881118754680PMID 29444621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond

  2019cited by this paper
• The Role of Lipidomics in Autism Spectrum Disorder

  2019cited by this paper
• Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs

  2019cited by this paper
• ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles

  2017cited by this paper
• Current view and perspectives in amyotrophic lateral sclerosis

  2017cited by this paper
• Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.

  2017cited by this paper
• CNS inflammation and neurodegeneration.

  2017cited by this paper
• APP as a Protective Factor in Acute Neuronal Insults

  2017cited by this paper
• Calcium and Parkinson's disease.

  2017cited by this paper
• O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity

  2017cited by this paper
• Efficacy of Memantine in Schizophrenic Patients: A Systematic Review

  2017cited by this paper
• Parkinson disease

  2017cited by this paper
• Altered kynurenine pathway metabolism in autism: Implication for immune‐induced glutamatergic activity

  2016cited by this paper
• Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model

  2016cited by this paper
• Elevated plasma levels of glutamate in children with autism spectrum disorders

  2016cited by this paper
• Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

  2016cited by this paper
• Adult Mental Disorders

  2016cited by this paper
• An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation

  2016cited by this paper
• Mechanisms of tau and Aβ-induced excitotoxicity.

  2016cited by this paper
• Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke

  2016cited by this paper
• Serum levels of SOD and risk of autism spectrum disorder: A case‐control study

  2016cited by this paper
• Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease

  2016cited by this paper
• Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis

  2016cited by this paper
• Adult Neurogenesis and Psychiatric Disorders.

  2016cited by this paper
• Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders

  2016cited by this paper
• Adult neurogenesis in neurodegenerative diseases.

  2015cited by this paper
• Dynamics and modulation of metabotropic glutamate receptors.

  2015cited by this paper
• Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study

  2015cited by this paper
• A comprehensive review of amyotrophic lateral sclerosis

  2015cited by this paper
• Ketamine and other glutamate receptor modulators for depression in adults

  2015cited by this paper
• Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases

  2015cited by this paper
• Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington's disease

  2015cited by this paper
• Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis

  2015cited by this paper
• The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010

  2015cited by this paper
• Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death

  2014cited by this paper
• Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex

  2014cited by this paper
• Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies

  2014cited by this paper
• GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders

  2014cited by this paper
• Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy?

  2014cited by this paper
• A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

  2014cited by this paper
• Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

  2014cited by this paper
• The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.

  2014cited by this paper
• Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?

  2014cited by this paper
• Glutamate-mediated excitotoxicity in schizophrenia: a review.

  2014cited by this paper
• Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

  2013cited by this paper
• Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

  2013cited by this paper
• Phase II safety, tolerability, and dose selection study of isradipine as a potential disease‐modifying intervention in early Parkinson's disease (STEADY‐PD)

  2013cited by this paper
• Increased Glutamate Concentration in the Auditory Cortex of Persons With Autism and First‐Degree Relatives: A 1H‐MRS Study

  2013cited by this paper
• Neuroinflammation and psychiatric illness

  2013cited by this paper
• Excitotoxicity and Wallerian degeneration as a processes related to cell death in nervous system.

  2013cited by this paper
• Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

  2013cited by this paper
• Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

  2013cited by this paper
• Inflammation, neurotoxins and psychiatric disorders.

  2013cited by this paper
• Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression

  2013cited by this paper
• Synapses and Alzheimer's disease.

  2012cited by this paper
• Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

  2012cited by this paper
• Excitotoxicity in the Pathogenesis of Autism

  2012cited by this paper
• Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

  2012cited by this paper
• Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders

  2012cited by this paper
• Quinolinic acid, the inescapable neurotoxin

  2012cited by this paper
• Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

  2012cited by this paper
• GABAergic interneuron origin of schizophrenia pathophysiology.

  2012cited by this paper
• Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation

  2012cited by this paper
• Kynurenines in the mammalian brain: when physiology meets pathology

  2012cited by this paper
• The role of the kynurenine metabolism in major depression

  2012cited by this paper
• Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease*

  2012cited by this paper
• Connecting inflammation with glutamate agonism in suicidality

  2012cited by this paper
• Trafficking and proteolytic processing of APP.

  2012cited by this paper
• Nitric oxide signaling: classical, less classical, and nonclassical mechanisms.

  2011cited by this paper
• Weathering the storm: living with Parkinson's disease.

  2011cited by this paper
• Metabotropic Glutamate Receptor 5 Upregulation in Children with Autism is Associated with Underexpression of Both Fragile X Mental Retardation Protein and GABAA Receptor Beta 3 in Adults with Autism

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cited by this paper
• Family-based association testing of glutamate transporter genes in autism.

  2011cited by this paper
• Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

  2011cited by this paper
• Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

  2011cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1

  2010cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper
• A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease

  2010cited by this paper
• Glutamate receptors, neurotoxicity and neurodegeneration

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Pathogenic Lysosomal Depletion in Parkinson's Disease

  2010cited by this paper
• Oxidative stress caused by mitochondrial calcium overload

  2010cited by this paper
• Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study

  2009cited by this paper
• Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation

  2009cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.

  2009cited by this paper
• Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.

  2009cited by this paper
• NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation

  2009cited by this paper
• Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease

  2008cited by this paper
• Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

  2007cited by this paper
• Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

  2007cited by this paper
• What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

  2007cited by this paper
• Mapping autism risk loci using genetic linkage and chromosomal rearrangements

  2007cited by this paper
• Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.

  2007cited by this paper
• A retrospective study of memantine in children and adolescents with pervasive developmental disorders

  2007cited by this paper

• Micronutrients and bioactive compounds in neuroprotection: Potential, mechanisms, and dietary sources

  2026cites this paper
• Schismogenesis in anxiety spectrum disorders: a biopsychosocial perspective

  2026cites this paper
• A Narrative Review of Synaptic Transmission and Its Role in Neurological and Psychiatric Disorders: A Molecular Perspective

  2026cites this paper
• CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions.

  2026cites this paper
• Multi-Scale Temporal Homeostasis Enables Efficient and Robust Neural Networks

  2026cites this paper
• The serum trace metal signature distinguishes patients with psychiatric disorders from healthy controls

  2025cites this paper
• Casticin inhibits the release of synaptic vesicular glutamate from rat hippocampal nerve terminals.

  2025cites this paper
• Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.

  2025cites this paper
• Biological functions and detection strategies of magnesium ions: from basic necessity to precise analysis.

  2025cites this paper
• Dysmagnesemia Incidence in Hospitalized Dogs and Cats: A Retrospective Study

  2025cites this paper
• Gut microbiota and blood metabolites: unveiling their roles in hippocampal volume changes through Mendelian randomization and mediation analysis

  2025cites this paper
• Plasma and urinary metabolomic signatures differentiate genetic and idiopathic Parkinson's disease.

  2025cites this paper
• Exploring Medical Gas Therapy in Hemorrhagic Stroke Treatment: A Narrative Review.

  2025cites this paper
• Mito-Apocynin Protects Against Kainic Acid-Induced Excitotoxicity by Ameliorating Mitochondrial Impairment

  2025cites this paper
• Glutamate Receptor Signaling in Retina Müller Cells: Plausible Role in Neurodegeneration

  2025cites this paper
• Reduction in presynaptic glutamate release and the prevention of glutamate excitotoxicity by lupeol in rats.

  2025cites this paper
• Magnesium and Migraine

  2025cites this paper
• Unveiling the Therapeutic Promise of Epigenetics in Vascular Cognitive Impairment and Vascular Dementia

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2025cites this paper
• Butein suppresses depolarization-evoked glutamate release by modulating P/Q-type Ca2+ channels and protein kinase C pathway in rat cortical synaptosomes.

  2025cites this paper
• Mitochondrial Dynamics in Neurodegenerative Diseases: Research Hotspots and Trends from 2005 to 2025.

  2025cites this paper
• Targeting Neuroinflammation in Synaptic Dysfunction: Translational Pharmacology for Neurodegenerative and Neuropsychiatric Disorders

  2025cites this paper
• Inhibitory regulation of glutamate release from rat cortical nerve terminals by thymoquinone.

  2025cites this paper
• Gypenoside XVII Reduces Synaptic Glutamate Release and Protects against Excitotoxic Injury in Rats

  2024cites this paper
• Uncovering metabolic dysregulation in schizophrenia and cannabis use disorder through untargeted plasma lipidomics

  2024cites this paper
• Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target

  2024cites this paper
• Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicity

  2024cites this paper
• Evaluation of neurotransmitters (Gamma-aminobutyric acid and serotonin) and apoptosis factor (Caspase-7) as biomarkers for the diagnosis of autism spectrum disorder

  2024cites this paper
• CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress

  2024cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Stress-Relieving Effects of Green Tea Depend on the Ratio of Its Special Ingredients and the Infusion Conditions

  2024cites this paper
• The influence of glutamate receptors on insulin release and diabetic neuropathy.

  2024cites this paper
• Effects of long-term magnesium L-threonate supplementation on neuroinflammation, demyelination and blood-brain barrier integrity in mice with neuromyelitis optica spectrum disorder.

  2024cites this paper
• Gene Expression at the Tripartite Synapse: Bridging the Gap Between Neurons and Astrocytes.

  2024cites this paper
• Unveiling the role of astrogliosis in Alzheimer's disease Pathology: Insights into mechanisms and therapeutic approaches.

  2024cites this paper
• GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients

  2024cites this paper
• Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders

  2024cites this paper
• Increased excitatory amino acid transporter 2 levels in basolateral amygdala astrocytes mediate chronic stress–induced anxiety-like behavior

  2024cites this paper
• Phillygenin Suppresses Glutamate Exocytosis in Rat Cerebrocortical Nerve Terminals (Synaptosomes) through the Inhibition of Cav2.2 Calcium Channels

  2024cites this paper
• The Importance of Iron, Copper, Zinc, and Magnesium Dyshomeostasis in terms of Alzheimer’s Disease and Possible Mechanisms

  2024cites this paper
• The Janus face of antipsychotics in glial cells: Focus on glioprotection

  2023cites this paper
• Glutamatergic Neurotransmission: A Potential Pharmacotherapeutic Target for the Treatment of Cognitive Disorders.

  2023cites this paper
• Integrated serum, urine metabolomics and 16S rRNA sequencing to investigate the modulatory effect of Ziziphi Spinosae Folium flavonoid on D-galactose-induced aging of rats

  2023cites this paper
• Psychotic decompensation in the course of SARS-COV-2 infection - case report

  2023cites this paper
• Ursolic acid inhibits the synaptic release of glutamate and prevents glutamate excitotoxicity in rats.

  2023cites this paper
• Research on Xiaoyao Powder in the treatment of depression based on epigenetics and quality markers

  2023cites this paper
• Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis

  2023cites this paper
• Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis

  2023cites this paper
• Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission.

  2023cites this paper
• Neuroprotective Effects of Albizia lebbeck (L.) Benth. Leaf Extract against Glutamate-Induced Endoplasmic Reticulum Stress and Apoptosis in Human Microglial Cells

  2023influential citation
• The pharmacological bases for repurposing statins in depression: a review of mechanistic studies

  2023cites this paper
• Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease

  2023cites this paper
• siRNA drug delivery across the blood-brain barrier in Alzheimer's Disease.

  2023cites this paper
• A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities

  2023cites this paper
• Cynarin, a caffeoylquinic acid derivative in artichoke, inhibits exocytotic glutamate release from rat cortical nerve terminals (synaptosomes).

  2023cites this paper
• Mangiferin depresses vesicular glutamate release in synaptosomes from the rat cerebral cortex by decreasing synapsin I phosphorylation.

  2023cites this paper
• Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder

  2023cites this paper
• Oxidative stress as a bridge between age and stroke: A narrative review

  2023cites this paper
• Evaluation of Neural Regulation and Microglial Responses to Brain Injury in Larval Zebrafish Exposed to Perfluorooctane Sulfonate

  2023cites this paper
• Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease

  2023cites this paper
• Neuroprotective Effects of Agri-Food By-Products Rich in Phenolic Compounds

  2023cites this paper
• Neuroprotective Effects of Neuropeptide Y on Human Neuroblastoma SH-SY5Y Cells in Glutamate Excitotoxicity and ER Stress Conditions

  2022cites this paper
• Molecular Mechanism of Tetramethylpyrazine Ameliorating Neuroexcitotoxicity through Activating the PKA/CREB Signaling Pathway

  2022cites this paper
• Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome

  2022cites this paper
• Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity

  2022cites this paper
• N-Acetylcysteine Mitigates Social Dysfunction in a Rat Model of Autism Normalizing Glutathione Imbalance and the Altered Expression of Genes Related to Synaptic Function in Specific Brain Areas

  2022cites this paper
• Genetics of glutamate and its receptors in autism spectrum disorder

  2022cites this paper
• The novel rapid-acting neurosteroid-based antidepressant generation

  2022cites this paper
• New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate Excitotoxicity.

  2022cites this paper
• Restoration of Sarco/Endoplasmic Reticulum Ca2+-ATPase Activity Functions as a Pivotal Therapeutic Target of Anti-Glutamate-Induced Excitotoxicity to Attenuate Endoplasmic Reticulum Ca2+ Depletion

  2022cites this paper
• Piperine Provides Neuroprotection against Kainic Acid-Induced Neurotoxicity via Maintaining NGF Signalling Pathway

  2022cites this paper
• Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities

  2022cites this paper
• Microglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets

  2022cites this paper
• Reply to Skokou, M. Comment on “Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158”

  2022cites this paper
• Astrocytes and Microglia in Stress-Induced Neuroinflammation: The African Perspective

  2022cites this paper
• Protective Effects of Bee Pollen on Multiple Propionic Acid-Induced Biochemical Autistic Features in a Rat Model

  2022cites this paper
• Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression

  2022cites this paper
• Targeting neuronal nitric oxide synthase and the nitrergic system in post-traumatic stress disorder

  2022cites this paper
• Alterations in Astrocytic Regulation of Excitation and Inhibition by Stress Exposure and in Severe Psychopathology

  2022cites this paper
• Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases

  2022cites this paper
• Insights into the role of pERK1/2 signaling in post-cerebral ischemia reperfusion sexual dysfunction in rats.

  2022cites this paper
• Inhibition of Synaptic Glutamate Exocytosis and Prevention of Glutamate Neurotoxicity by Eupatilin from Artemisia argyi in the Rat Cortex

  2022influential citation
• Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders.

  2022cites this paper
• Regulatory Effects of Curcumin on Platelets: An Update and Future Directions

  2022cites this paper
• Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions

  2021cites this paper
• Review of nanotheranostics for molecular mechanisms underlying psychiatric disorders and commensurate nanotherapeutics for neuropsychiatry: The mind knockout

  2021cites this paper
• The impact of glutathione metabolism in autism spectrum disorder.

  2021cites this paper
• Sulbactam improves binding property and uptake capacity of glutamate transporter-1 and decreases glutamate concentration in the CA1 region of hippocampus of global brain ischemic rats

  2021cites this paper
• The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Neurochemical Mechanisms of Pathogenesis and Pharmacological Correction of Autism Spectrum Disorders: Current Concepts and Prospects

  2021cites this paper
• Micronutrients May Be a Unique Weapon Against the Neurotoxic Triad of Excitotoxicity, Oxidative Stress and Neuroinflammation: A Perspective

  2021cites this paper
• Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers

  2021cites this paper
• The neuroprotective potential of carotenoids in vitro and in vivo.

  2021cites this paper
• Pathogenesis of Neurodegeneration and Associated Neurological Disorders

  2021cites this paper
• Resveratrol prevents long-term structural hippocampal alterations and modulates interneuron organization in an animal model of ASD.

  2021cites this paper
• Astaxanthin prevents mitochondrial impairment in the dopaminergic SH-SY5Y cell line exposed to glutamate-mediated excitotoxicity: Role for the Nrf2/HO-1/CO-BR axis.

  2021cites this paper
• Negative Feedback Role of Astrocytes in Shaping Excitation in Brain Cell Co-cultures

  2021cites this paper
• Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease

  2021cites this paper
• On the Role of Vascularization in Pathoconnectomics

  2021cites this paper
• Amyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity

  2021cites this paper